- Home
- QTRX
as 12-20-2024 4:00pm EST
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | BILLERICA |
| Market Cap: | 439.1M | IPO Year: | 2017 |
| Target Price: | $23.25 | AVG Volume (30 days): | 375.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.04 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.87 - $29.70 | Next Earning Date: | 11-12-2024 |
| Revenue: | $129,330,000 | Revenue Growth: | 15.52% |
| Revenue Growth (this year): | 13.89% | Revenue Growth (next year): | 15.51% |
Latest Quanterix Corporation News
QTRX Breaking Stock News: Dive into QTRX Ticker-Specific Updates for Smart Investing
MT Newswires
5 days ago
Quanterix Plans to Acquire Emission for $10 Million in Cash
Business Wire
5 days ago
Quanterix Expands Capabilities with Strategic Acquisition of EMISSION
Business Wire
a month ago
Quanterix Announces Receipt of Expected Notice from Nasdaq
GuruFocus.com
a month ago
Quanterix Corp (QTRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Instrument ...
Business Wire
a month ago
Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024
GuruFocus.com
a month ago
Quanterix Corp (QTRX) Q3 2024: Everything You Need To Know Ahead Of Earnings
Business Wire
2 months ago
Quanterix To Report Third Quarter 2024 Financial Results on November 12, 2024
Business Wire
2 months ago
New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer’s Disease Diagnostic Information
Compare QTRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "QTRX Quanterix Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.